Preparing for hospital price transparency — Stark CEO update 10/7/20

Preparing for hospital price transparency — Stark CEO update 10/7/20

This week, Stark CEO Mick Raich reviews the hospital price transparency rules that will take effect Jan. 1 and outlines why they may not be a big deal for larger health systems. He also looks at a new policy change from UHC to require G0416 for prostate biopsies across all products and discusses recent high profile healthcare cyber security breaches, among other topics.

Leave a Reply

Your email address will not be published. Required fields are marked *